Clinical Trial Update: Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study assessing gepotidacin (GSK2140944) in adults with varying hepatic impairment compared to matched controls; results posted after c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Bacterial

Drugs mentioned

• gepoti dacin (gep otidacin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED | Results posted: 2019-12-17